Log In
BCIQ
Print this Print this
 

CD20

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting CD20

BCIQ
Print ChartPrint this
Marketed, 1 Marketed, 6 Marketed, 1 Approved, 1 Registration, 2 Phase III, 8 Phase III, 7 Phase II, 4 Phase II, 3 Phase I/II, 8 Phase I/II, 3 Phase I, 8 Phase I, 3 Preclinical, 11 Preclinical, 3 Discovery, 2 Discovery, 2
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase IIIRegistrationApprovedMarketed
Autoimmune

2

3

3

3

3

7

-

-

1

Cancer

2

11

8

8

4

8

2

1

6

Inflammation

-

-

-

-

-

-

-

-

1




 Products Targeting CD20
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

21

$17,728.2M

$15,020.3M

$2,679.7M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today